ArticleClinical and translational radiation oncology2026

Daily adaptive radiotherapy in head and neck squamous cell carcinoma can negatively impact organ at risk dosimetry.

Hedda Enocson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.